Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets

Research output: Contribution to journal › Article

Cite this

@article{f66339d01dfd45e88eec5fbbd1899ffd,

title = "Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets",

author = "Souza, {Rhonda F.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/j.jcmgh.2018.01.020",

language = "English (US)",

journal = "Cellular and Molecular Gastroenterology and Hepatology",

issn = "2352-345X",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Esophageal Adenocarcinomas

T2 - A Need for Speed Driven by Immune Pathways That Have Druggable Targets

AU - Souza, Rhonda F.

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85044611112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044611112&partnerID=8YFLogxK

U2 - 10.1016/j.jcmgh.2018.01.020

DO - 10.1016/j.jcmgh.2018.01.020

M3 - Article

C2 - 29713671

AN - SCOPUS:85044611112

JO - Cellular and Molecular Gastroenterology and Hepatology

JF - Cellular and Molecular Gastroenterology and Hepatology

SN - 2352-345X

ER -